Thursday, March 10, 2011

First lupus drug in half a century approved

A therapeutic antibody is the first success in a wave of experimental therapies aimed at tackling the autoimmune disease.

Thursday, January 13, 2011

UCB Announces Start of Phase III Program with Epratuzumab for Patients with Moderate to Severe SLE

Tuesday, December 14, 2010

Children with Lupus Have More Lethal Form of Kidney Disease

Vigilant monitoring, aggressive treatment recommended

Tuesday, November 9, 2010

Epratuzumab Phase IIb Study Shows Positive Effect in Moderate to Severe S.L.E.

Monday, November 8, 2010

People with Lupus Might Be At Greater Risk for Cancer

November 2010

Monday, November 8, 2010

Statins Not Routinely Indicated for Children and Adolescents with Lupus

November 2010

Monday, November 8, 2010

Researchers Find Clue to Preventing Heart Complications Associated with Neonatal Lupus

November 2010

Monday, November 8, 2010

People with Rheumatoid Arthritis and Lupus Often Skip Their Medications

November 2010

Thursday, August 19, 2010

Glaxo, Human Genome Get Fast Review for Lupus Drug

FDA move means Benlysta could be approved by Dec. 9

Thursday, August 12, 2010

NIH launches effort to define markers of human immune responses

Recovery Act enables research that could help improve vaccines and therapeutics